Long Non-Coding RNAs as “MYC Facilitators”
Abstract
:1. Introduction
2. Main text
2.1. Technical Considerations
2.2. SNHG17
2.3. LNROP
3. Concluding Considerations
Funding
Conflicts of Interest
References
- DePinho, R.; Mitsock, L.; Hatton, K.; Ferrier, P.; Zimmerman, K.; Legouy, E.; Tesfaye, A.; Collum, R.; Yancopoulos, G.; Nisen, P.; et al. Myc family of cellular oncogenes. J. Cell Biochem. 1987, 33, 257–266. [Google Scholar] [CrossRef] [PubMed]
- Kurihara, Y.; Horiuchi, M.; Ukita, S.; Katahira, M.; Uesugi, S. DNA binding properties of c-Myc-related bHLH/LZ oncoproteins. Nucleic Acids Symp. Ser. 1993, 29, 169–170. [Google Scholar]
- Diolaiti, D.; McFerrin, L.; Carroll, P.A.; Eisenman, R.N. Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis. Biochim. Biophys. Acta 2015, 1849, 484–500. [Google Scholar] [CrossRef] [PubMed]
- Grandori, C.; Cowley, S.M.; James, L.P.; Eisenman, R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 2000, 16, 653–699. [Google Scholar] [CrossRef] [PubMed]
- Gabay, M.; Li, Y.; Felsher, D.W. MYC activation is a hallmark of cancer initiation and maintenance. Cold Spring Harb. Perspect. Med. 2014, 4, a014241. [Google Scholar] [CrossRef]
- Prendergast, G.C.; Ziff, E.B. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science 1991, 251, 186–189. [Google Scholar] [CrossRef]
- Das, S.K.; Lewis, B.A.; Levens, D. MYC: A complex problem. Trends Cell Biol. 2023, 33, 235–246. [Google Scholar] [CrossRef]
- Lin, C.Y.; Loven, J.; Rahl, P.B.; Paranal, R.M.; Burge, C.B.; Bradner, J.E.; Lee, T.I.; Young, R.A. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151, 56–67. [Google Scholar] [CrossRef]
- Nie, Z.; Guo, C.; Das, S.K.; Chow, C.C.; Batchelor, E.; Simons, S.S.J.; Levens, D. Dissecting transcriptional amplification by MYC. Elife 2020, 9, e52483. [Google Scholar] [CrossRef]
- Patange, S.; Ball, D.A.; Wan, Y.; Karpova, T.S.; Girvan, M.; Levens, D.; Larson, D.R. MYC amplifies gene expression through global changes in transcription factor dynamics. Cell Rep. 2022, 38, 110292. [Google Scholar] [CrossRef]
- Weber, L.I.; Hartl, M. Strategies to target the cancer driver MYC in tumor cells. Front. Oncol. 2023, 13, 1142111. [Google Scholar] [CrossRef] [PubMed]
- Langenau, D.M.; Traver, D.; Ferrando, A.A.; Kutok, J.L.; Aster, J.C.; Kanki, J.P.; Lin, S.; Prochownik, E.; Trede, N.S.; Zon, L.I.; et al. Myc-induced T cell leukemia in transgenic zebrafish. Science 2003, 299, 887–890. [Google Scholar] [CrossRef] [PubMed]
- Coller, H.A.; Grandori, C.; Tamayo, P.; Colbert, T.; Lander, E.S.; Eisenman, R.N.; Golub, T.R. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc. Natl. Acad. Sci. USA 2000, 97, 3260–3265. [Google Scholar] [CrossRef] [PubMed]
- Carroll, P.A.; Freie, B.W.; Mathsyaraja, H.; Eisenman, R.N. The MYC transcription factor network: Balancing metabolism, proliferation and oncogenesis. Front. Med. 2018, 12, 412–425. [Google Scholar] [CrossRef]
- Garcia-Gutierrez, L.; Delgado, M.D.; Leon, J. MYC Oncogene Contributions to Release of Cell Cycle Brakes. Genes 2019, 10, 244. [Google Scholar] [CrossRef]
- Grzes, M.; Oron, M.; Staszczak, Z.; Jaiswar, A.; Nowak-Niezgoda, M.; Walerych, D. A Driver Never Works Alone-Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer. Cancers 2020, 12, 1532. [Google Scholar] [CrossRef]
- Llombart, V.; Mansour, M.R. Therapeutic targeting of “undruggable” MYC. EBioMedicine 2022, 75, 103756. [Google Scholar] [CrossRef]
- Prochownik, E.V. Regulation of Normal and Neoplastic Proliferation and Metabolism by the Extended Myc Network. Cells 2022, 11, 3974. [Google Scholar] [CrossRef]
- Li, J.; Dong, T.; Wu, Z.; Zhu, D.; Gu, H. The effects of MYC on tumor immunity and immunotherapy. Cell Death Discov. 2023, 9, 103. [Google Scholar] [CrossRef]
- Dhanasekaran, R.; Deutzmann, A.; Mahauad-Fernandez, W.D.; Hansen, A.S.; Gouw, A.M.; Felsher, D.W. The MYC oncogene—The grand orchestrator of cancer growth and immune evasion. Nat. Rev. Clin. Oncol. 2022, 19, 23–36. [Google Scholar] [CrossRef]
- Conacci-Sorrell, M.; McFerrin, L.; Eisenman, R.N. An overview of MYC and its interactome. Cold Spring Harb. Perspect. Med. 2014, 4, a014357. [Google Scholar] [CrossRef] [PubMed]
- Duesberg, P.H.; Bister, K.; Vogt, P.K. The RNA of avian acute leukemia virus MC29. Proc. Natl. Acad. Sci. USA 1977, 74, 4320–4324. [Google Scholar] [CrossRef] [PubMed]
- Kalkat, M.; De Melo, J.; Hickman, K.A.; Lourenco, C.; Redel, C.; Resetca, D.; Tamachi, A.; Tu, W.B.; Penn, L.Z. MYC Deregulation in Primary Human Cancers. Genes 2017, 8, 151. [Google Scholar] [CrossRef] [PubMed]
- Gauwerky, C.E.; Croce, C.M. Chromosomal translocations in leukaemia. Semin. Cancer Biol. 1993, 4, 333–340. [Google Scholar]
- Croce, C.M. Molecular biology of lymphomas. Semin. Oncol. 1993, 20, 31–46. [Google Scholar]
- Truica, M.I.; Burns, M.C.; Han, H.; Abdulkadir, S.A. Turning Up the Heat on MYC: Progress in Small-Molecule Inhibitors. Cancer Res. 2021, 81, 248–253. [Google Scholar] [CrossRef]
- D’Avola, A.; Kluckova, K.; Finch, A.J.; Riches, J.C. Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers. Onco Targets Ther. 2023, 16, 371–383. [Google Scholar] [CrossRef]
- Karadkhelkar, N.M.; Lin, M.; Eubanks, L.M.; Janda, K.D. Demystifying the Druggability of the MYC Family of Oncogenes. J. Am. Chem. Soc. 2023, 145, 3259–3269. [Google Scholar] [CrossRef]
- Madden, S.K.; de Araujo, A.D.; Gerhardt, M.; Fairlie, D.P.; Mason, J.M. Taking the Myc out of cancer: Toward therapeutic strategies to directly inhibit c-Myc. Mol. Cancer 2021, 20, 3. [Google Scholar] [CrossRef]
- Wang, C.; Zhang, J.; Yin, J.; Gan, Y.; Xu, S.; Gu, Y.; Huang, W. Alternative approaches to target Myc for cancer treatment. Signal Transduct. Target. Ther. 2021, 6, 117. [Google Scholar] [CrossRef]
- Herrmann, H.; Blatt, K.; Shi, J.; Gleixner, K.V.; Cerny-Reiterer, S.; Mullauer, L.; Vakoc, C.R.; Sperr, W.R.; Horny, H.P.; Bradner, J.E.; et al. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML. Oncotarget 2012, 3, 1588–1599. [Google Scholar] [CrossRef] [PubMed]
- Delmore, J.E.; Issa, G.C.; Lemieux, M.E.; Rahl, P.B.; Shi, J.; Jacobs, H.M.; Kastritis, E.; Gilpatrick, T.; Paranal, R.M.; Qi, J.; et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146, 904–917. [Google Scholar] [CrossRef] [PubMed]
- Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W.B.; Fedorov, O.; Morse, E.M.; Keates, T.; Hickman, T.T.; Felletar, I.; et al. Selective inhibition of BET bromodomains. Nature 2010, 468, 1067–1073. [Google Scholar] [CrossRef] [PubMed]
- Prochownik, E.V.; Wang, H. Normal and Neoplastic Growth Suppression by the Extended Myc Network. Cells 2022, 11, 747. [Google Scholar] [CrossRef]
- Taft, R.J.; Mattick, J.S. Increasing biological complexity is positively correlated with the relative genome-wide expansion of non-protein-coding DNA sequences. Genome Biol. 2003, 5, P1. [Google Scholar] [CrossRef]
- Morris, K.V.; Mattick, J.S. The rise of regulatory RNA. Nat. Rev. Genet. 2014, 15, 423–437. [Google Scholar] [CrossRef]
- Ponting, C.P.; Haerty, W. Genome-Wide Analysis of Human Long Noncoding RNAs: A Provocative Review. Annu. Rev. Genom. Hum. Genet. 2022, 23, 153–172. [Google Scholar] [CrossRef]
- Mattick, J.S. A Kuhnian revolution in molecular biology: Most genes in complex organisms express regulatory RNAs. Bioessays 2023, 2300080. [Google Scholar] [CrossRef]
- Mattick, J.S.; Amaral, P.P.; Carninci, P.; Carpenter, S.; Chang, H.Y.; Chen, L.L.; Chen, R.; Dean, C.; Dinger, M.E.; Fitzgerald, K.A.; et al. Long non-coding RNAs: Definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell Biol. 2023, 24, 430–447. [Google Scholar] [CrossRef]
- Stokes, T.; Cen, H.H.; Kapranov, P.; Gallagher, I.J.; Pitsillides, A.A.; Volmar, C.H.; Kraus, W.E.; Johnson, J.D.; Phillips, S.M.; Wahlestedt, C.; et al. Transcriptomics for Clinical and Experimental Biology Research: Hang on a Seq. Adv. Genet. 2023, 4, 2200024. [Google Scholar] [CrossRef]
- Long, Y.; Wang, X.; Youmans, D.T.; Cech, T.R. How do lncRNAs regulate transcription? Sci. Adv. 2017, 3, eaao2110. [Google Scholar] [CrossRef] [PubMed]
- Davidovich, C.; Cech, T.R. The recruitment of chromatin modifiers by long noncoding RNAs: Lessons from PRC2. RNA 2015, 21, 2007–2022. [Google Scholar] [CrossRef] [PubMed]
- Statello, L.; Guo, C.J.; Chen, L.L.; Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell Biol. 2021, 22, 96–118. [Google Scholar] [CrossRef]
- Pajic, A.; Spitkovsky, D.; Christoph, B.; Kempkes, B.; Schuhmacher, M.; Staege, M.S.; Brielmeier, M.; Ellwart, J.; Kohlhuber, F.; Bornkamm, G.W.; et al. Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int. J. Cancer 2000, 87, 787–793. [Google Scholar] [CrossRef]
- Winkle, M.; van den Berg, A.; Tayari, M.; Sietzema, J.; Terpstra, M.; Kortman, G.; de Jong, D.; Visser, L.; Diepstra, A.; Kok, K.; et al. Long noncoding RNAs as a novel component of the Myc transcriptional network. FASEB J. 2015, 29, 2338–2346. [Google Scholar] [CrossRef]
- Hart, J.R.; Roberts, T.C.; Weinberg, M.S.; Morris, K.V.; Vogt, P.K. MYC regulates the non-coding transcriptome. Oncotarget 2014, 5, 12543–12554. [Google Scholar] [CrossRef] [PubMed]
- Jahangiri, L.; Pucci, P.; Ishola, T.; Trigg, R.M.; Williams, J.A.; Pereira, J.; Cavanagh, M.L.; Turner, S.D.; Gkoutos, G.V.; Tsaprouni, L. The Contribution of Autophagy and LncRNAs to MYC-Driven Gene Regulatory Networks in Cancers. Int. J. Mol. Sci. 2021, 22, 8527. [Google Scholar] [CrossRef]
- Stasevich, E.M.; Murashko, M.M.; Zinevich, L.S.; Demin, D.E.; Schwartz, A.M. The Role of Non-Coding RNAs in the Regulation of the Proto-Oncogene MYC in Different Types of Cancer. Biomedicines 2021, 9, 921. [Google Scholar] [CrossRef]
- Arman, K.; Moroy, T. Crosstalk Between MYC and lncRNAs in Hematological Malignancies. Front. Oncol. 2020, 10, 579940. [Google Scholar] [CrossRef]
- Fatma, H.; Siddique, H.R. Role of long non-coding RNAs and MYC interaction in cancer metastasis: A possible target for therapeutic intervention. Toxicol. Appl. Pharmacol. 2020, 399, 115056. [Google Scholar] [CrossRef]
- Swier, L.; Dzikiewicz-Krawczyk, A.; Winkle, M.; van den Berg, A.; Kluiver, J. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer. Mol. Oncol. 2019, 13, 26–45. [Google Scholar] [CrossRef] [PubMed]
- Xiang, J.F.; Yang, L.; Chen, L.L. The long noncoding RNA regulation at the MYC locus. Curr. Opin. Genet. Dev. 2015, 33, 41–48. [Google Scholar] [CrossRef] [PubMed]
- Andergassen, D.; Rinn, J.L. From genotype to phenotype: Genetics of mammalian long non-coding RNAs in vivo. Nat. Rev. Genet. 2022, 23, 229–243. [Google Scholar] [CrossRef] [PubMed]
- Zibitt, M.S.; Hartford, C.C.R.; Lal, A. Interrogating lncRNA functions via CRISPR/Cas systems. RNA Biol. 2021, 18, 2097–2106. [Google Scholar] [CrossRef] [PubMed]
- Morelli, E.; Gulla, A.; Amodio, N.; Taiana, E.; Neri, A.; Fulciniti, M.; Munshi, N.C. CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA Network. Methods Mol. Biol. 2021, 2348, 189–204. [Google Scholar] [CrossRef]
- Liu, S.J.; Horlbeck, M.A.; Cho, S.W.; Birk, H.S.; Malatesta, M.; He, D.; Attenello, F.J.; Villalta, J.E.; Cho, M.Y.; Chen, Y.; et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 2017, 355, aah7111. [Google Scholar] [CrossRef]
- Qi, L.S.; Larson, M.H.; Gilbert, L.A.; Doudna, J.A.; Weissman, J.S.; Arkin, A.P.; Lim, W.A. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 2013, 152, 1173–1183. [Google Scholar] [CrossRef]
- Raffeiner, P.; Hart, J.R.; Garcia-Caballero, D.; Bar-Peled, L.; Weinberg, M.S.; Vogt, P.K. An MXD1-derived repressor peptide identifies noncoding mediators of MYC-driven cell proliferation. Proc. Natl. Acad. Sci. USA 2020, 117, 6571–6579. [Google Scholar] [CrossRef]
- Erb, M.A.; Scott, T.G.; Li, B.E.; Xie, H.; Paulk, J.; Seo, H.S.; Souza, A.; Roberts, J.M.; Dastjerdi, S.; Buckley, D.L.; et al. Transcription control by the ENL YEATS domain in acute leukaemia. Nature 2017, 543, 270–274. [Google Scholar] [CrossRef]
- Cai, Z.; Cao, C.; Ji, L.; Ye, R.; Wang, D.; Xia, C.; Wang, S.; Du, Z.; Hu, N.; Yu, X.; et al. RIC-seq for global in situ profiling of RNA-RNA spatial interactions. Nature 2020, 582, 432–437. [Google Scholar] [CrossRef]
- Bonetti, A.; Agostini, F.; Suzuki, A.M.; Hashimoto, K.; Pascarella, G.; Gimenez, J.; Roos, L.; Nash, A.J.; Ghilotti, M.; Cameron, C.J.F.; et al. RADICL-seq identifies general and cell type-specific principles of genome-wide RNA-chromatin interactions. Nat. Commun. 2020, 11, 1018. [Google Scholar] [CrossRef] [PubMed]
- Zhou, B.; Li, X.; Luo, D.; Lim, D.H.; Zhou, Y.; Fu, X.D. GRID-seq for comprehensive analysis of global RNA-chromatin interactions. Nat. Protoc. 2019, 14, 2036–2068. [Google Scholar] [CrossRef] [PubMed]
- Li, X.; Zhou, B.; Chen, L.; Gou, L.T.; Li, H.; Fu, X.D. GRID-seq reveals the global RNA-chromatin interactome. Nat. Biotechnol. 2017, 35, 940–950. [Google Scholar] [CrossRef] [PubMed]
- Esposito, R.; Lanzos, A.; Uroda, T.; Ramnarayanan, S.; Buchi, I.; Polidori, T.; Guillen-Ramirez, H.; Mihaljevic, A.; Merlin, B.M.; Mela, L.; et al. Tumour mutations in long noncoding RNAs enhance cell fitness. Nat. Commun. 2023, 14, 3342. [Google Scholar] [CrossRef] [PubMed]
- Deng, Y.; Luo, S.; Zhang, X.; Zou, C.; Yuan, H.; Liao, G.; Xu, L.; Deng, C.; Lan, Y.; Zhao, T.; et al. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs. Mol. Oncol. 2018, 12, 1980–2005. [Google Scholar] [CrossRef]
- Lanzos, A.; Carlevaro-Fita, J.; Mularoni, L.; Reverter, F.; Palumbo, E.; Guigo, R.; Johnson, R. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features. Sci. Rep. 2017, 7, 41544. [Google Scholar] [CrossRef]
- Chen, W.; Wang, L.; Li, X.; Zhao, C.; Shi, L.; Zhao, H.; Huang, C. LncRNA SNHG17 regulates cell proliferation and invasion by targeting miR-338-3p/SOX4 axis in esophageal squamous cell carcinoma. Cell Death Dis. 2021, 12, 806. [Google Scholar] [CrossRef]
- Ge, B.H.; Li, G.C. Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis. J. Gene Med. 2020, 22, e3247. [Google Scholar] [CrossRef]
- Liu, J.Y.; Chen, Y.J.; Feng, H.H.; Chen, Z.L.; Wang, Y.L.; Yang, J.E.; Zhuang, S.M. LncRNA SNHG17 interacts with LRPPRC to stabilize c-Myc protein and promote G1/S transition and cell proliferation. Cell Death Dis. 2021, 12, 970. [Google Scholar] [CrossRef]
- Liu, Y.; Li, Q.; Tang, D.; Li, M.; Zhao, P.; Yang, W.; Shu, L.; Wang, J.; He, Z.; Li, Y.; et al. SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis. Cancer Cell Int. 2020, 20, 566. [Google Scholar] [CrossRef]
- Ma, L.; Gao, J.; Zhang, N.; Wang, J.; Xu, T.; Lei, T.; Zou, X.; Wei, C.; Wang, Z. Long noncoding RNA SNHG17: A novel molecule in human cancers. Cancer Cell Int. 2022, 22, 104. [Google Scholar] [CrossRef] [PubMed]
- Xu, T.; Yan, S.; Jiang, L.; Yu, S.; Lei, T.; Yang, D.; Lu, B.; Wei, C.; Zhang, E.; Wang, Z. Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer. Mol. Ther. Nucleic Acids 2019, 17, 405–413. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.; Xu, Y.; Wang, S.; Gong, Z.; Zou, C.; Zhang, H.; Ma, G.; Zhang, W.; Jiang, P. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57. J. Cell Physiol. 2019, 234, 5163–5174. [Google Scholar] [CrossRef] [PubMed]
- Zhao, A.; Zhao, Z.; Liu, W.; Cui, X.; Wang, N.; Wang, Y.; Wang, Y.; Sun, L.; Xue, H.; Wu, L.; et al. Carcinoma-associated fibroblasts promote the proliferation and metastasis of osteosarcoma by transferring exosomal LncRNA SNHG17. Am. J. Transl. Res. 2021, 13, 10094–10111. [Google Scholar] [PubMed]
- Ma, Z.; Gu, S.; Song, M.; Yan, C.; Hui, B.; Ji, H.; Wang, J.; Zhang, J.; Wang, K.; Zhao, Q. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Mol. Biosyst. 2017, 13, 2350–2361. [Google Scholar] [CrossRef] [PubMed]
- Zhang, G.; Fu, L.; Wang, Y.; Liu, B.; Ma, S.; Ma, H.; Zhang, H.; Zhang, F.; Yang, K.; Cai, H. Integrative pan-cancer analysis indicates the prognostic importance of long noncoding RNA SNHG17 in human cancers. Pathol. Res. Pract. 2022, 238, 154140. [Google Scholar] [CrossRef]
- Qiao, C.; Qiao, T.; Yang, S.; Liu, L.; Zheng, M. SNHG17/miR-384/ELF1 axis promotes cell growth by transcriptional regulation of CTNNB1 to activate Wnt/beta-catenin pathway in oral squamous cell carcinoma. Cancer Gene Ther. 2022, 29, 122–132. [Google Scholar] [CrossRef]
- Gao, H.; Liu, R.; Sun, X. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway. Eur. Rev. Med. Pharmacol. Sci. 2019, 23, 8000–8010. [Google Scholar] [CrossRef]
- Pan, X.; Guo, Z.; Chen, Y.; Zheng, S.; Peng, M.; Yang, Y.; Wang, Z. STAT3-Induced lncRNA SNHG17 Exerts Oncogenic Effects on Ovarian Cancer through Regulating CDK6. Mol. Ther. Nucleic Acids 2020, 22, 38–49. [Google Scholar] [CrossRef]
- Ma, T.; Zhou, X.; Wei, H.; Yan, S.; Hui, Y.; Liu, Y.; Guo, H.; Li, Q.; Li, J.; Chang, Z.; et al. Long Non-coding RNA SNHG17 Upregulates RFX1 by Sponging miR-3180-3p and Promotes Cellular Function in Hepatocellular Carcinoma. Front. Genet. 2020, 11, 607636. [Google Scholar] [CrossRef]
- Li, J.; Du, B.; Geng, X.; Zhou, L. lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values. Diabetes Metab. Syndr. Obes. 2021, 14, 831–838. [Google Scholar] [CrossRef]
- Guo, F.; Wang, W.; Song, Y.; Wu, L.; Wang, J.; Zhao, Y.; Ma, X.; Ji, H.; Liu, Y.; Li, Z.; et al. LncRNA SNHG17 knockdown promotes Parkin-dependent mitophagy and reduces apoptosis of podocytes through Mst1. Cell Cycle 2020, 19, 1997–2006. [Google Scholar] [CrossRef] [PubMed]
- Deveson, I.W.; Brunck, M.E.; Blackburn, J.; Tseng, E.; Hon, T.; Clark, T.A.; Clark, M.B.; Crawford, J.; Dinger, M.E.; Nielsen, L.K.; et al. Universal Alternative Splicing of Noncoding Exons. Cell Syst. 2018, 6, 245–255.e245. [Google Scholar] [CrossRef] [PubMed]
- Garcia-Caballero, D.; Hart, J.R.; Vogt, P.K. The MYC-regulated lncRNA LNROP (ENSG00000254887) enables MYC-driven cell proliferation by controlling the expression of OCT2. Cell Death Dis. 2023, 14, 168. [Google Scholar] [CrossRef] [PubMed]
- Wirth, T.; Pfisterer, P.; Annweiler, A.; Zwilling, S.; Konig, H. Molecular principles of Oct2-mediated gene activation in B cells. Immunobiology 1995, 193, 161–170. [Google Scholar] [CrossRef]
- Song, S.; Cao, C.; Choukrallah, M.A.; Tang, F.; Christofori, G.; Kohler, H.; Wu, F.; Fodor, B.D.; Frederiksen, M.; Willis, S.N.; et al. OBF1 and Oct factors control the germinal center transcriptional program. Blood 2021, 137, 2920–2934. [Google Scholar] [CrossRef]
- Latchman, D.S. The Oct-2 transcription factor. Int. J. Biochem. Cell Biol. 1996, 28, 1081–1083. [Google Scholar] [CrossRef]
- Hodson, D.J.; Shaffer, A.L.; Xiao, W.; Wright, G.W.; Schmitz, R.; Phelan, J.D.; Yang, Y.; Webster, D.E.; Rui, L.; Kohlhammer, H.; et al. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc. Natl. Acad. Sci. USA 2016, 113, E2039–E2046. [Google Scholar] [CrossRef]
- Varone, A.; Spano, D.; Corda, D. Shp1 in Solid Cancers and Their Therapy. Front. Oncol. 2020, 10, 935. [Google Scholar] [CrossRef]
- Neel, B.G.; Gu, H.; Pao, L. The ‘Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem. Sci. 2003, 28, 284–293. [Google Scholar] [CrossRef]
- Lopez-Ruiz, P.; Rodriguez-Ubreva, J.; Cariaga, A.E.; Cortes, M.A.; Colas, B. SHP-1 in cell-cycle regulation. Anticancer Agents Med. Chem. 2011, 11, 89–98. [Google Scholar] [CrossRef] [PubMed]
- Kawakami, T.; Xiao, W.; Yasudo, H.; Kawakami, Y. Regulation of proliferation, survival, differentiation, and activation by the Signaling Platform for SHP-1 phosphatase. Adv. Biol. Regul. 2012, 52, 7–15. [Google Scholar] [CrossRef] [PubMed]
- Hasler, P.; Zouali, M. B cell receptor signaling and autoimmunity. FASEB J. 2001, 15, 2085–2098. [Google Scholar] [CrossRef] [PubMed]
- Dempke, W.C.M.; Uciechowski, P.; Fenchel, K.; Chevassut, T. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment? Oncology 2018, 95, 257–269. [Google Scholar] [CrossRef]
- An, H.; Hou, J.; Zhou, J.; Zhao, W.; Xu, H.; Zheng, Y.; Yu, Y.; Liu, S.; Cao, X. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol. 2008, 9, 542–550. [Google Scholar] [CrossRef]
- Wu, C.; Sun, M.; Liu, L.; Zhou, G.W. The function of the protein tyrosine phosphatase SHP-1 in cancer. Gene 2003, 306, 1–12. [Google Scholar] [CrossRef]
- Deveson, I.W.; Hardwick, S.A.; Mercer, T.R.; Mattick, J.S. The Dimensions, Dynamics, and Relevance of the Mammalian Noncoding Transcriptome. Trends Genet. 2017, 33, 464–478. [Google Scholar] [CrossRef]
- Mattick, J.S.; Rinn, J.L. Discovery and annotation of long noncoding RNAs. Nat. Struct. Mol. Biol. 2015, 22, 5–7. [Google Scholar] [CrossRef]
- Begik, O.; Lucas, M.C.; Liu, H.; Ramirez, J.M.; Mattick, J.S.; Novoa, E.M. Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures. Genome Biol. 2020, 21, 97. [Google Scholar] [CrossRef]
- Iaccarino, I. lncRNAs and MYC: An Intricate Relationship. Int. J. Mol. Sci. 2017, 18, 1497. [Google Scholar] [CrossRef]
- Deng, K.; Guo, X.; Wang, H.; Xia, J. The lncRNA-MYC regulatory network in cancer. Tumour Biol. 2014, 35, 9497–9503. [Google Scholar] [CrossRef] [PubMed]
- Huang, W.; Chen, Q.; Lu, Y.; Kong, Z.; Wan, X.; Huang, Y.; Qiu, M.; Li, Y. Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer. Int. J. Mol. Sci. 2022, 23, 12219. [Google Scholar] [CrossRef] [PubMed]
- Yang, K.; Zhang, W.; Zhong, L.; Xiao, Y.; Sahoo, S.; Fassan, M.; Zeng, K.; Magee, P.; Garofalo, M.; Shi, L. Long non-coding RNA HIF1A-As2 and MYC form a double-positive feedback loop to promote cell proliferation and metastasis in KRAS-driven non-small cell lung cancer. Cell Death Differ. 2023, 30, 1533–1549. [Google Scholar] [CrossRef] [PubMed]
- Liu, P.; Wang, J.; Du, W.; Chen, L. LncRNA SNHG12 promotes proliferation and migration of hepatic progenitor cells via the Wnt/beta-catenin pathway. Adv. Clin. Exp. Med. 2023. [Google Scholar] [CrossRef]
- Ke, M.; Sun, N.; Lin, Z.; Zhang, P.; Hu, Y.; Wu, S.; Zheng, Z.; Lu, Y.; Jin, H. SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein. Cancer Cell Int. 2023, 23, 48. [Google Scholar] [CrossRef]
- Guo, R.; Su, Y.; Zhang, Q.; Xiu, B.; Huang, S.; Chi, W.; Zhang, L.; Li, L.; Hou, J.; Wang, J.; et al. LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets. J. Transl. Med. 2023, 21, 120. [Google Scholar] [CrossRef]
- Ayer, D.E.; Eisenman, R.N. A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes. Dev. 1993, 7, 2110–2119. [Google Scholar] [CrossRef]
- Roy, A.L.; Carruthers, C.; Gutjahr, T.; Roeder, R.G. Direct role for Myc in transcription initiation mediated by interactions with TFII-I. Nature 1993, 365, 359–361. [Google Scholar] [CrossRef]
- Ellenberger, T.; Fass, D.; Arnaud, M.; Harrison, S.C. Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes Dev. 1994, 8, 970–980. [Google Scholar] [CrossRef]
- Shoji, W.; Yamamoto, T.; Obinata, M. The helix-loop-helix protein Id inhibits differentiation of murine erythroleukemia cells. J. Biol. Chem. 1994, 269, 5078–5084. [Google Scholar] [CrossRef]
- Oksuz, O.; Henninger, J.E.; Warneford-Thomson, R.; Zheng, M.M.; Erb, H.; Vancura, A.; Overholt, K.J.; Hawken, S.W.; Banani, S.F.; Lauman, R.; et al. Transcription factors interact with RNA to regulate genes. Mol. Cell 2023, 83, 2449–2463. [Google Scholar] [CrossRef]
- Patel, S.; Sexton, A.N.; Strine, M.S.; Wilen, C.B.; Simon, M.D.; Pyle, A.M. Systematic detection of tertiary structural modules in large RNAs and RNP interfaces by Tb-seq. Nat. Commun. 2023, 14, 3426. [Google Scholar] [CrossRef]
- Guttman, M.; Rinn, J.L. Modular regulatory principles of large non-coding RNAs. Nature 2012, 482, 339–346. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
García-Caballero, D.; Hart, J.R.; Vogt, P.K. Long Non-Coding RNAs as “MYC Facilitators”. Pathophysiology 2023, 30, 389-399. https://doi.org/10.3390/pathophysiology30030030
García-Caballero D, Hart JR, Vogt PK. Long Non-Coding RNAs as “MYC Facilitators”. Pathophysiology. 2023; 30(3):389-399. https://doi.org/10.3390/pathophysiology30030030
Chicago/Turabian StyleGarcía-Caballero, Daniel, Jonathan R. Hart, and Peter K. Vogt. 2023. "Long Non-Coding RNAs as “MYC Facilitators”" Pathophysiology 30, no. 3: 389-399. https://doi.org/10.3390/pathophysiology30030030